Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Registrati

Quotazioni in diretta

MLAB Mesa Laboratories Inc

135,62

4,37 (3,33%)

Dopo l'orario di negoziazione

Ultimo aggiornamento: 23:05:18

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

09/13/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

06/12/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Brian D. Archbold

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Mesa Laboratories (NASDAQ:MLAB)
Storico
Da Nov 2024 a Dic 2024

Clicca qui per i Grafici di Mesa Laboratories

Grafico Azioni Mesa Laboratories (NASDAQ:MLAB)
Storico
Da Dic 2023 a Dic 2024

Clicca qui per i Grafici di Mesa Laboratories

Notizie Mesa Laboratories Inc - MLAB

Form 4 - Statement of changes in beneficial ownership of securities
Lunedì 25 Novembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Giovedì 7 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Form 8-K - Current report
Giovedì 7 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Mesa Labs Announces Second Quarter Results
Giovedì 7 Novembre 2024 (2 mesi fa) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 30 Ottobre 2024 (2 mesi fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Martedì 29 Ottobre 2024 (2 mesi fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunedì 28 Ottobre 2024 (2 mesi fa) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Martedì 15 Ottobre 2024 (2 mesi fa) • Edgar (US Regulatory)

MESA LABS DECLARES QUARTERLY DIVIDEND
Mercoledì 2 Ottobre 2024 (3 mesi fa) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Lunedì 16 Settembre 2024 (3 mesi fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Venerdì 13 Settembre 2024 (3 mesi fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Venerdì 6 Settembre 2024 (4 mesi fa) • Edgar (US Regulatory)

Più Mesa Laboratories Inc Articoli Notizie

Intesa Sanpaolo

Banca Monte Dei Paschi D...

ST Microelectronics

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea